- Home
- ROIV vs CWST Comparison
ROIV vs CWST Comparison
Compare ROIV & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CWST
- Stock Information
- Founded
- ROIV 2014
- CWST 1975
- Country
- ROIV United Kingdom
- CWST United States
- Employees
- ROIV N/A
- CWST N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CWST Environmental Services
- Sector
- ROIV Health Care
- CWST Utilities
- Exchange
- ROIV Nasdaq
- CWST Nasdaq
- Market Cap
- ROIV 8.4B
- CWST 7.5B
- IPO Year
- ROIV N/A
- CWST 1997
- Fundamental
- Price
- ROIV $10.67
- CWST $110.02
- Analyst Decision
- ROIV Buy
- CWST Strong Buy
- Analyst Count
- ROIV 4
- CWST 7
- Target Price
- ROIV $17.50
- CWST $122.67
- AVG Volume (30 Days)
- ROIV 5.9M
- CWST 580.1K
- Earning Date
- ROIV 05-29-2025
- CWST 05-01-2025
- Dividend Yield
- ROIV N/A
- CWST N/A
- EPS Growth
- ROIV N/A
- CWST N/A
- EPS
- ROIV N/A
- CWST 0.21
- Revenue
- ROIV $122,585,000.00
- CWST $1,633,376,000.00
- Revenue This Year
- ROIV N/A
- CWST $17.45
- Revenue Next Year
- ROIV N/A
- CWST $6.94
- P/E Ratio
- ROIV N/A
- CWST $527.74
- Revenue Growth
- ROIV 140.04
- CWST 21.63
- 52 Week Low
- ROIV $8.73
- CWST $88.89
- 52 Week High
- ROIV $13.06
- CWST $120.69
- Technical
- Relative Strength Index (RSI)
- ROIV 47.82
- CWST 37.49
- Support Level
- ROIV $10.58
- CWST $111.92
- Resistance Level
- ROIV $11.77
- CWST $119.71
- Average True Range (ATR)
- ROIV 0.34
- CWST 3.24
- MACD
- ROIV -0.07
- CWST -0.95
- Stochastic Oscillator
- ROIV 7.56
- CWST 7.43
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.